Please assess the completion status of the following clinical trial:

Trial Title: Burst Suppression Anesthesia for Treatment of Severe Depression

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* • Diagnosis of Major Depressive Disorder (MDD) or bipolar Disorder (I or II, most recent episode must be depression~  * Failed at least 2 anti-depressant treatments and no ECT in past 6 months~ * Age between 18-55 years~ * BMI \< 35~ * Hamilton Rating Scale for Depression (HSRD) score \> 18~ * Quick Inventory of Depression Scale (QIDS) score \> 10.~Exclusion Criteria:~* • Diagnosis of primary psychotic disorder, dysthymia, or personality disorder~  * Significant pre-morbid cognitive impairment~ * Hypertension and current use of ACE inhibitor or AR blocker medications~ * Symptomatic coronary artery disease or congestive heart failure~ * History of transient ischemic or neurologic signs during the past year~ * History of or susceptibility to malignant hyperthermia~ * Contraindication to isoflurane or propofol anesthesia (as determined by anesthesiologist)~ * Diabetes requiring insulin~ * Poor kidney function~ * Chronic use of benzodiazepines or opioids~ * Individuals incompetent to provide consent (e.g. catatonic, psychotic).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- Propofol (Type: EXPERIMENTAL): Participants will receive intravenous propofol titrated rapidly at 100-200 mcg/kg/min to reach 80% burst-suppression and then maintained there for 15 minutes, after which propofol administration will be discontinued and the participant will be allowed to awaken.

Based on this trial design, predict the completion outcome and termination type (if applicable).